Porton Capital Group

Porton Capital Group is a private equity and venture capital firm that specialized in the commercialization of intellectual property developed by the UK Ministry of Defence's Defence Science and Technology Laboratory (Dstl). Based in Dubai with operations in the UK and Cayman Islands, the firm focused on high-growth technology sectors, particularly life sciences, molecular diagnostics, and defense technologies. It is best known for its lead investment in Enigma Diagnostics, a company that developed point-of-care PCR testing systems. The firm gained significant notoriety in the early 2010s due to its involvement in a high-profile UK political scandal and subsequent legal disputes. While it played a key role in the early 2000s technology transfer landscape, the firm is currently largely inactive following the dissolution of its primary UK entities and ongoing legal challenges involving its leadership.